Honouring the companies, scientists and pioneers shaping biotech, biopharma and health science across Asia-Pacific — recognising performance in Calendar Year 2025.
I am honoured to serve as the Guest of Honour at the BioSpectrum Asia Excellence Awards 2026. Recognising excellence is more important than ever in today's rapidly evolving healthcare and biotechnology landscape.
Behind every breakthrough therapy, diagnostic advancement, medical technology, research discovery, or entrepreneurial success are dedicated individuals and organisations working to address some of society's most pressing health challenges. By celebrating these achievements, we not only recognise their contributions but also inspire future generations of scientists, entrepreneurs, clinicians, and industry leaders to pursue bold ideas that improve lives.
These Awards showcase the breadth of talent, leadership, and partnership across the life sciences community. Beyond scientific and technological achievements, they recognise the collaborative efforts required to translate discoveries into meaningful healthcare, industry, and societal outcomes. Such accomplishments underscore the importance of bringing together academia, healthcare, industry, and the broader innovation ecosystem to create lasting impact.
”I encourage organisations, innovators and leaders from across the Asia-Pacific life sciences community to participate in the nomination process and help us recognise the individuals and organisations whose work is making a meaningful impact across the region.
Conceived in 2008 and held across Asia since 2009, the BioSpectrum Asia Excellence Awards bring the region's decision-makers into one room for one night — and turn that night into a year of recognition.
The strongest performers across biotech, biopharma, contract services, drug discovery and AI — judged by an independent international jury.
A gala of C-suite leaders, founders, investors and policymakers from eight markets — the most senior life-sciences room in Asia.
Winners revealed live on stage, capped by the Lifetime Achievement honour — a tribute to those who built Asian life sciences.
Industry Segmentation awards by category and new-for-2026 categories tracking the modalities defining the year ahead.
Everything you need to know before submitting your nomination - eligibility, category requirements, and how entries are evaluated for Calendar Year 2025 & H1 2026.
To be eligible for an award, the project, service or initiative must be either:
The BioSpectrum Asia Excellence Awards 2026 comprise 35 categories across three tiers. Categories marked Nominations Closed are no longer accepting entries; the rest remain open, recognising performance in Calendar Year 2025 & H1 2026.
The online portal opens to self-nominations and editorial nominations across all categories.
Final call for submissions. Entries enter editorial due-diligence and validation.
An independent international jury scores entries blind; shortlists are published.
A thought-leadership panel, the awards ceremony and a seated gala dinner — Singapore.
Winners are selected by an independent panel of academics, industry veterans, investors and policy leaders — drawn from across Asia-Pacific to avoid any single-market bias.
Director of Public & International Affairs
Korea Biotechnology Industry Organization
Lecturer · NTU School of Chemistry, Chemical Engineering and Biotechnology
President · Malaysian Society for Molecular Biology and Biotechnology (MSMBB)
Secretary-General · Taiwan BIO
President of Singapore Society for Microbiology and Biotechnology
Professor, Peking University
Chairman, Hong Kong Biotechnology Organization (HKBIO)
Chairman, Guangdong-Hong Kong-Macau Greater Bay Area Biotechnology Alliance
(GBABA)
President, BIOHK
Advisor, Life Sciences · Government of Telangana, India
Nominate your company, a product, a leader or a peer. Self-nominations and third-party nominations are both welcome across every category.